IOL Chemicals gets Korean approval for Ibuprofen, Fenofibrate
New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products -- Ibuprofen and Fenofibrate.The approval by the Korean Ministry of Food and Drug Safety re-establishes the company's efforts to keep the highest quality standards and to increase presence in...
New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products -- Ibuprofen and Fenofibrate.
The approval by the Korean Ministry of Food and Drug Safety re-establishes the company's efforts to keep the highest quality standards and to increase presence in the regulated markets, IOL Chemicals & Pharmaceuticals said in a regulatory filing.
Also Read: Lupin Launches Generic Equivalent Of Northera Capsules In US
This will strengthen the company's presence in the South Korean market, it added.
Ibuprofen is used to treat a range of aches and pains, including back pain, period pain and toothache. Fenofibrate is used to treat the symptoms of high cholesterol and triglycerides in the blood.
Also Read: Lupin Unveils Generic Duexis Tablets In US
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd